Cite Filings / ALDX / 0001193125-14-189017

Feed Companies Filings Check

Sign in

8-K

Current Report

Aldeyra Therapeutics, Inc. Filed 2014-05-08 Acc 0001193125-14-189017

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , d722587d8k.htm

Around this filing

2014-06-11 8-K Results of operations
2014-05-08 4 Director bought 12,500 shares at $8.00 ($100,000)
2014-05-08 4 Director bought 12,500 shares at $8.00 ($100,000)
2014-05-08 4 President and CEO bought 12,500 shares at $8.00 ($100,000)
2014-05-08 4 Director bought 9,375 shares at $8.00 ($75,000)
2014-05-08 8-K Regulation FD disclosure
2014-05-07 8-K Bylaws or fiscal year change

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d722587d8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…